Litcius/Paper detail

Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma

Bo Xu

2022European Journal of Clinical Pharmacology23 citationsDOI

Topics & Concepts

MedicineDiffuse large B-cell lymphomaRefractory (planetary science)LymphomaInternal medicineOncologyChemotherapyClinical trialRadiation therapyToxicityRadiologyCarmustineCancer researchCancerMEDLINECAR-T cell therapy researchLymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia research
Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma | Litcius